Graphique illustrant l’évolution de la consommation de drogues en France

Drugs in France: Recent Trends to Know

The drug landscape in France is evolving. The increased availability of cocaine, the persistence of cannabis, the use of MDMA or ketamine, and the emergence of new substances require adapting prevention efforts.

Why avoid the term “hard drugs”?

This expression is common, but it oversimplifies the risks. The danger depends on the molecule, dose, purity, method of consumption, mixtures, frequency, and the person’s situation.

A product considered “less dangerous” can cause a serious accident in certain circumstances, while the same substance does not have the same consequences for all users.

The rise of cocaine

French monitoring systems describe cocaine as more accessible and present in diverse social environments. Use is not limited to festive contexts: it can also be linked to performance enhancement, night work, stress, or private consumption.

Main risks include cardiovascular complications, anxiety disorders, addiction, and accidents related to disinhibition. Mixing with alcohol or other stimulants increases unpredictability.

Cannabis remains a major issue

Cannabis remains very prevalent. THC concentrations can vary greatly depending on the product, especially with certain resins, flowers, or extracts. Synthetic cannabinoids, sometimes sold under misleading presentations, should not be confused with classic cannabis.

A product name does not guarantee its composition. A powder, tablet, puff, liquid, or gummy may contain a different substance than announced, at an unknown concentration.

MDMA, ketamine, and new substances

MDMA is often associated with party settings, but its dosage can vary from one tablet to another. Hyperthermia, dehydration, confusion, and cardiovascular complications are among the possible risks.

Ketamine can cause dissociation, loss of coordination, and consciousness disorders. Synthetic cathinones and other new psychoactive substances change rapidly, complicating their identification and detection.

Polyconsumption increases risk

  • alcohol and cocaine: increased cardiovascular strain;
  • alcohol and sedatives: higher risk of loss of consciousness and respiratory depression;
  • multiple stimulants: agitation, hyperthermia, and cardiac complications;
  • products of unknown composition: unpredictable effects and interactions.
In case of chest pain, seizures, difficulty breathing, severe agitation, or loss of consciousness, call 15 or 112 immediately.

Adapting prevention

Prevention must combine information, harm reduction, access to care, and testing adapted to the context. A rapid test only detects substances included in its panel, and a negative result does not exclude another molecule.

Institutional reference: the French Observatory of Drugs and Addictive Behaviors regularly publishes data on use, markets, and emerging phenomena.
Back to blog

Leave a comment

Please note, comments need to be approved before they are published.